Related Experiment Video
Updated: Nov 27, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.6K
[COVID-19, state of medical knowledge]
Cyril Sellier1, Maëlys Herisson1
1Service de médecine gériatrique, Assistance publique-Hôpitaux de Paris, université Paris-Saclay, site Ambroise-Paré, 9 avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Soins. Gerontologie
|December 5, 2020
Summary
Coronavirus disease 2019 (COVID-19) is a severe respiratory infection, especially in the elderly. Therapeutics remain limited, emphasizing the need for preventive measures.
Area of Science:
- Infectious Diseases
- Public Health
- Gerontology
Background:
- Coronavirus disease 2019 (COVID-19) emerged as a significant global health crisis.
- The disease primarily manifests as a viral respiratory infection with varied symptomatology.
- Elderly individuals represent a high-risk group for severe COVID-19 outcomes.
Purpose of the Study:
- To highlight the challenges in treating COVID-19, particularly in the elderly.
- To underscore the current limitations in available therapeutics for this demographic.
- To emphasize the critical role of preventive strategies in managing the pandemic.
Main Methods:
- Review of current scientific literature on COVID-19.
- Analysis of epidemiological data concerning disease severity in different age groups.
- Assessment of the existing therapeutic landscape for COVID-19.
Main Results:
- COVID-19 poses a substantial threat, with increased severity observed in older populations.
- Current therapeutic options for COVID-19 are limited, especially for elderly patients.
- Preventive measures are crucial due to therapeutic constraints.
Conclusions:
- The elderly are particularly vulnerable to severe COVID-19, necessitating targeted protective measures.
- The limited availability of effective treatments underscores the importance of public health interventions.
- Continued research and development of therapeutics are essential, but immediate focus must remain on prevention.
Keywords:
COVID-19Covid-19elderlyfacteur de risquepreventionpréventionrisk factorsujet âgétherapeuticsthérapeutiquetransmissionMore Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.1K
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
5.2K
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
17.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.5K
01:26Principles of Disease Surveillance
344
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
344
00:36Viral Mutations
38.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.1K
01:18Steps in Outbreak Investigation
369
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
369
01:13Controls in Experiments
14.4K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.4K
01:29Microorganisms in Medicine and Therapeutics
690
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
690